Report cover image

Global Oral Vaccine for Human Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20355859

Description

Summary

According to APO Research, The global Oral Vaccine for Human market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Vaccine for Human is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Vaccine for Human is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oral Vaccine for Human is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oral Vaccine for Human is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oral Vaccine for Human include Bibcol, Bio-Med, EuBiologics, Halfkin Bio-Pharmaceuticals, Panacea Biotec Ltd, PaxVax, Serum Institute, Vabiotech and Valneva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Vaccine for Human, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oral Vaccine for Human, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccine for Human, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Vaccine for Human sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Vaccine for Human market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Vaccine for Human sales, projected growth trends, production technology, application and end-user industry.

Oral Vaccine for Human Segment by Company

Bibcol
Bio-Med
EuBiologics
Halfkin Bio-Pharmaceuticals
Panacea Biotec Ltd
PaxVax
Serum Institute
Vabiotech
Valneva
Tiantan Biological
GSK
Merck
Sanofi
Shanghai United Cell
Lanzhou Institute
Oral Vaccine for Human Segment by Type

Cholera Vaccine
Oral Polio Vaccine
Rotavirus Vaccine
Other
Oral Vaccine for Human Segment by Application

Public
Private
Oral Vaccine for Human Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccine for Human market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccine for Human and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccine for Human.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccine for Human market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccine for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccine for Human in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Vaccine for Human in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Oral Vaccine for Human Market Size, 2020 VS 2024 VS 2031
1.3 Global Oral Vaccine for Human Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oral Vaccine for Human Sales Estimates and Forecasts (2020-2031)
1.5 Global Oral Vaccine for Human Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oral Vaccine for Human Market Dynamics
2.1 Oral Vaccine for Human Industry Trends
2.2 Oral Vaccine for Human Industry Drivers
2.3 Oral Vaccine for Human Industry Opportunities and Challenges
2.4 Oral Vaccine for Human Industry Restraints
3 Oral Vaccine for Human Market by Manufacturers
3.1 Global Oral Vaccine for Human Revenue by Manufacturers (2020-2025)
3.2 Global Oral Vaccine for Human Sales by Manufacturers (2020-2025)
3.3 Global Oral Vaccine for Human Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oral Vaccine for Human Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral Vaccine for Human Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral Vaccine for Human Manufacturers, Product Type & Application
3.7 Global Oral Vaccine for Human Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccine for Human Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccine for Human Players Market Share by Revenue in 2024
3.8.3 2024 Oral Vaccine for Human Tier 1, Tier 2, and Tier 3
4 Oral Vaccine for Human Market by Type
4.1 Oral Vaccine for Human Type Introduction
4.1.1 Cholera Vaccine
4.1.2 Oral Polio Vaccine
4.1.3 Rotavirus Vaccine
4.1.4 Other
4.2 Global Oral Vaccine for Human Sales by Type
4.2.1 Global Oral Vaccine for Human Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oral Vaccine for Human Sales by Type (2020-2031)
4.2.3 Global Oral Vaccine for Human Sales Market Share by Type (2020-2031)
4.3 Global Oral Vaccine for Human Revenue by Type
4.3.1 Global Oral Vaccine for Human Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oral Vaccine for Human Revenue by Type (2020-2031)
4.3.3 Global Oral Vaccine for Human Revenue Market Share by Type (2020-2031)
5 Oral Vaccine for Human Market by Application
5.1 Oral Vaccine for Human Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccine for Human Sales by Application
5.2.1 Global Oral Vaccine for Human Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oral Vaccine for Human Sales by Application (2020-2031)
5.2.3 Global Oral Vaccine for Human Sales Market Share by Application (2020-2031)
5.3 Global Oral Vaccine for Human Revenue by Application
5.3.1 Global Oral Vaccine for Human Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oral Vaccine for Human Revenue by Application (2020-2031)
5.3.3 Global Oral Vaccine for Human Revenue Market Share by Application (2020-2031)
6 Global Oral Vaccine for Human Sales by Region
6.1 Global Oral Vaccine for Human Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oral Vaccine for Human Sales by Region (2020-2031)
6.2.1 Global Oral Vaccine for Human Sales by Region (2020-2025)
6.2.2 Global Oral Vaccine for Human Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral Vaccine for Human Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oral Vaccine for Human Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oral Vaccine for Human Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oral Vaccine for Human Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral Vaccine for Human Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oral Vaccine for Human Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oral Vaccine for Human Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oral Vaccine for Human Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oral Vaccine for Human Revenue by Region
7.1 Global Oral Vaccine for Human Revenue by Region
7.1.1 Global Oral Vaccine for Human Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oral Vaccine for Human Revenue by Region (2020-2025)
7.1.3 Global Oral Vaccine for Human Revenue by Region (2026-2031)
7.1.4 Global Oral Vaccine for Human Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oral Vaccine for Human Revenue (2020-2031)
7.2.2 North America Oral Vaccine for Human Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oral Vaccine for Human Revenue (2020-2031)
7.3.2 Europe Oral Vaccine for Human Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral Vaccine for Human Revenue (2020-2031)
7.4.2 Asia-Pacific Oral Vaccine for Human Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oral Vaccine for Human Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oral Vaccine for Human Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bibcol
8.1.1 Bibcol Comapny Information
8.1.2 Bibcol Business Overview
8.1.3 Bibcol Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bibcol Oral Vaccine for Human Product Portfolio
8.1.5 Bibcol Recent Developments
8.2 Bio-Med
8.2.1 Bio-Med Comapny Information
8.2.2 Bio-Med Business Overview
8.2.3 Bio-Med Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Bio-Med Oral Vaccine for Human Product Portfolio
8.2.5 Bio-Med Recent Developments
8.3 EuBiologics
8.3.1 EuBiologics Comapny Information
8.3.2 EuBiologics Business Overview
8.3.3 EuBiologics Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 EuBiologics Oral Vaccine for Human Product Portfolio
8.3.5 EuBiologics Recent Developments
8.4 Halfkin Bio-Pharmaceuticals
8.4.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.4.2 Halfkin Bio-Pharmaceuticals Business Overview
8.4.3 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product Portfolio
8.4.5 Halfkin Bio-Pharmaceuticals Recent Developments
8.5 Panacea Biotec Ltd
8.5.1 Panacea Biotec Ltd Comapny Information
8.5.2 Panacea Biotec Ltd Business Overview
8.5.3 Panacea Biotec Ltd Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Panacea Biotec Ltd Oral Vaccine for Human Product Portfolio
8.5.5 Panacea Biotec Ltd Recent Developments
8.6 PaxVax
8.6.1 PaxVax Comapny Information
8.6.2 PaxVax Business Overview
8.6.3 PaxVax Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 PaxVax Oral Vaccine for Human Product Portfolio
8.6.5 PaxVax Recent Developments
8.7 Serum Institute
8.7.1 Serum Institute Comapny Information
8.7.2 Serum Institute Business Overview
8.7.3 Serum Institute Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Serum Institute Oral Vaccine for Human Product Portfolio
8.7.5 Serum Institute Recent Developments
8.8 Vabiotech
8.8.1 Vabiotech Comapny Information
8.8.2 Vabiotech Business Overview
8.8.3 Vabiotech Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Vabiotech Oral Vaccine for Human Product Portfolio
8.8.5 Vabiotech Recent Developments
8.9 Valneva
8.9.1 Valneva Comapny Information
8.9.2 Valneva Business Overview
8.9.3 Valneva Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Valneva Oral Vaccine for Human Product Portfolio
8.9.5 Valneva Recent Developments
8.10 Tiantan Biological
8.10.1 Tiantan Biological Comapny Information
8.10.2 Tiantan Biological Business Overview
8.10.3 Tiantan Biological Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Tiantan Biological Oral Vaccine for Human Product Portfolio
8.10.5 Tiantan Biological Recent Developments
8.11 GSK
8.11.1 GSK Comapny Information
8.11.2 GSK Business Overview
8.11.3 GSK Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 GSK Oral Vaccine for Human Product Portfolio
8.11.5 GSK Recent Developments
8.12 Merck
8.12.1 Merck Comapny Information
8.12.2 Merck Business Overview
8.12.3 Merck Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Merck Oral Vaccine for Human Product Portfolio
8.12.5 Merck Recent Developments
8.13 Sanofi
8.13.1 Sanofi Comapny Information
8.13.2 Sanofi Business Overview
8.13.3 Sanofi Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Sanofi Oral Vaccine for Human Product Portfolio
8.13.5 Sanofi Recent Developments
8.14 Shanghai United Cell
8.14.1 Shanghai United Cell Comapny Information
8.14.2 Shanghai United Cell Business Overview
8.14.3 Shanghai United Cell Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Shanghai United Cell Oral Vaccine for Human Product Portfolio
8.14.5 Shanghai United Cell Recent Developments
8.15 Lanzhou Institute
8.15.1 Lanzhou Institute Comapny Information
8.15.2 Lanzhou Institute Business Overview
8.15.3 Lanzhou Institute Oral Vaccine for Human Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Lanzhou Institute Oral Vaccine for Human Product Portfolio
8.15.5 Lanzhou Institute Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oral Vaccine for Human Value Chain Analysis
9.1.1 Oral Vaccine for Human Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccine for Human Production Mode & Process
9.2 Oral Vaccine for Human Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccine for Human Distributors
9.2.3 Oral Vaccine for Human Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.